Recall: D-0150-2018

Class I - Dangerous

Class IClassification

2017-10-20Initiated

TerminatedStatus

Pfizer Inc.Firm

Product

diphenoxylate hydrochloride and atropine sulfate tablets, USP, 2.5 mg/0.025 mg, a) 100-count bottle (NDC 59762-1061-1), b) 1000-count bottle (NDC 59762-1061-2), Rx Only, Distributed by: Greenstone LLC. Peapack, NJ 07977

Reason

SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent

Distribution

Nationwide in the USA

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.